138 related articles for article (PubMed ID: 23171020)
1. Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial.
Dastgheib L; Naseri M; Mirashe Z
Int J Dermatol; 2012 Dec; 51(12):1508-11. PubMed ID: 23171020
[TBL] [Abstract][Full Text] [Related]
2. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
Sadeghian G; Nilforoushzadeh MA
Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol in the treatment of American cutaneous leishmaniasis.
Martinez S; Marr JJ
N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Krolewiecki AJ; Romero HD; Cajal SP; Abraham D; Mimori T; Matsumoto T; Juarez M; Taranto NJ
Am J Trop Med Hyg; 2007 Oct; 77(4):640-6. PubMed ID: 17978064
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
Momeni AZ; Aminjavaheri M
Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
Salmanpour R; Handjani F; Nouhpisheh MK
J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
[TBL] [Abstract][Full Text] [Related]
10. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
Rajabi O; Layegh P; Hashemzadeh S; Khoddami M
Dermatol Ther; 2016 Sep; 29(5):358-363. PubMed ID: 27073044
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.
Mohammadzadeh M; Behnaz F; Golshan Z
J Infect Public Health; 2013 Apr; 6(2):120-4. PubMed ID: 23537825
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
Esfandiarpour I; Dabiri SH
Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
[TBL] [Abstract][Full Text] [Related]
13. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil.
Toledo Junior A; Daher AB; Amaral TA; Carvalho SF; Romero GA; Rabello A
Rev Soc Bras Med Trop; 2014; 47(6):756-62. PubMed ID: 25626655
[TBL] [Abstract][Full Text] [Related]
14. A comparative study between the efficacy of oral cimetidine and low-dose systemic meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment of cutaneous leishmaniasis.
Shanehsaz SM; Ishkhanian S
Int J Dermatol; 2015 Jul; 54(7):834-8. PubMed ID: 26108265
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Esfandiarpour I; Alavi A
Int J Dermatol; 2002 Aug; 41(8):521-4. PubMed ID: 12207774
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
Munir A; Janjua SA; Hussain I
Acta Dermatovenerol Croat; 2008; 16(2):60-4. PubMed ID: 18541100
[TBL] [Abstract][Full Text] [Related]
17. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial.
Velez I; Agudelo S; Hendrickx E; Puerta J; Grogl M; Modabber F; Berman J
Ann Intern Med; 1997 Feb; 126(3):232-6. PubMed ID: 9027276
[TBL] [Abstract][Full Text] [Related]
18. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
Momeni AZ; Reiszadae MR; Aminjavaheri M
Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis.
Firdous R; Yasinzai M; Ranja K
Int J Dermatol; 2009 Jul; 48(7):758-62. PubMed ID: 19570087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
